Schedule 13G ownership disclosure

MALLINCKRODT PLC

Security class unavailable · CUSIP: G5785G107

Event date: 2015-08-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,727,201
Percent of class
4.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001103804-15-000050
Form type
SC 13G
Filer
Keenova Therapeutics plc
CIK
CIK 1567892
Filed
Aug 31, 2015
Reporting period
Aug 21, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub